Tigermed Investor

Tigermed is a contract research company providing whole process clinical trial services for the R&D of pharmaceuticals.Tigermed (Stock code: 300347.SZ/3347.HK) is a leading provider of innovative clinical research solutions across full lifecycle of biopharmaceutical and medical device products globally.
Industry: Biotechnology
Headquarters: China
Founded Date: 2004
Employees Number: 5001-10000
Funding Status: IPO
Investors Number: 1
Total Funding: 8300000 USD
Estimated Revenue: $100M to $500M
Last Funding Date: 2010-03-01
Last Funding Type: Venture - Series Unknown

Visit Website
bd@tigermed.net
Register and Claim Ownership